1-20 of 53
Authors: Samuel L Aitken
Save search
Sort by
Journal Article

311. Defining the magnitude of desirability of outcome ranking (DOOR) differences in effectiveness of Ceftazidime-Avibactam (CZA) versus Ceftolozane-Tazobactam (C/T) for multidrug-resistant (MDR) Pseudomonas aeruginosa infections in the United States (CACTUS)

PDF
jason M Pogue and others
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.101, https://doi.org/10.1093/ofid/ofae631.101
Published: 29 January 2025
Journal Article

312. Impact of Patient Subgroups on the Efficacy of Ceftazidime-Avibactam (CZA) versus Ceftolozane-Tazobactam (C/T) for Multidrug-resistant (MDR) Pseudomonas aeruginosa infections in the United States (CACTUS)

PDF
Michael P Veve and others
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.102, https://doi.org/10.1093/ofid/ofae631.102
Published: 29 January 2025
Journal Article

P-639. Development of antimicrobial resistance in patients with pneumonia due to P.aeruginosa treated with cefepime or piperacillin-tazobactam

PDF
Raneem H Pallotta and others
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.836, https://doi.org/10.1093/ofid/ofae631.836
Published: 29 January 2025
Journal Article
EDITOR'S CHOICE

A Comparison of Different Strategies for Optimizing the Selection of Empiric Antibiotic Therapy for Pneumonia Caused by Gram-Negative Bacteria in Intensive Care Units: Unit-Specific Combination Antibiograms Versus Patient-Specific Risk Factors

PDF
Walaiporn Wangchinda and others
Open Forum Infectious Diseases, Volume 11, Issue 11, November 2024, ofae643, https://doi.org/10.1093/ofid/ofae643
Published: 30 October 2024
Journal Article

Implementation of an Automated Antibiotic Time-out at a Comprehensive Cancer Center

PDF
Frank P Tverdek and others
Open Forum Infectious Diseases, Volume 11, Issue 5, May 2024, ofae235, https://doi.org/10.1093/ofid/ofae235
Published: 25 April 2024
Journal Article

Nut Cracked? Does the ACORN Trial End the Debate Surrounding Vancomycin and Piperacillin-Tazobactam Combination Therapy and Increased Risk for Acute Kidney Injury?

PDF
Jason M Pogue and Samuel L Aitken
Open Forum Infectious Diseases, Volume 11, Issue 1, January 2024, ofad645, https://doi.org/10.1093/ofid/ofad645
Published: 18 December 2023
Journal Article

1109. A multicenter, observational study to compare the effectiveness of Ceftazidime-Avibactam versus Ceftolozane-Tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the United States (CACTUS)

PDF
Ryan K Shields and others
Open Forum Infectious Diseases, Volume 10, Issue Supplement_2, December 2023, ofad500.082, https://doi.org/10.1093/ofid/ofad500.082
Published: 27 November 2023
Journal Article

355. Stratification of Patient-Specific Risk Factors for Multidrug-Resistant Gram-Negative Respiratory Pathogens in Intensive Care Units (ICU)

PDF
Walaiporn Wangchinda and others
Open Forum Infectious Diseases, Volume 10, Issue Supplement_2, December 2023, ofad500.426, https://doi.org/10.1093/ofid/ofad500.426
Published: 27 November 2023
Journal Article

356. Impact of CLSI Breakpoint Changes on Unit-Specific Combination Antibiograms for Gram-Negative Respiratory Isolates

PDF
Walaiporn Wangchinda and others
Open Forum Infectious Diseases, Volume 10, Issue Supplement_2, December 2023, ofad500.427, https://doi.org/10.1093/ofid/ofad500.427
Published: 27 November 2023
Journal Article

354. A Comparison of Different Strategies for Optimizing the Selection of Empiric Antibiotic Therapy for Hospital-Acquired Pneumonia (HAP) and Ventilator-Associated Pneumonia (VAP) Caused by Gram-Negative Bacteria in Intensive Care Units (ICU)

PDF
Walaiporn Wangchinda and others
Open Forum Infectious Diseases, Volume 10, Issue Supplement_2, December 2023, ofad500.425, https://doi.org/10.1093/ofid/ofad500.425
Published: 27 November 2023
Journal Article

In Vivo Emergence of Pandrug-Resistant Acinetobacter baumannii Strain: Comprehensive Resistance Characterization and Compassionate Use of Sulbactam-Durlobactam

PDF
Mollie VanNatta and others
Open Forum Infectious Diseases, Volume 10, Issue 10, October 2023, ofad504, https://doi.org/10.1093/ofid/ofad504
Published: 06 October 2023
Journal Article

Successful Treatment of Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Patients With Immunodeficiency With Extended Nirmatrelvir/Ritonavir: Case Series

PDF
Madison Breeden and others
Open Forum Infectious Diseases, Volume 10, Issue 4, April 2023, ofad189, https://doi.org/10.1093/ofid/ofad189
Published: 06 April 2023
Journal Article

1844. Mortality associated with Stenotrophomonas maltophilia bloodstream infection in patients with leukemia

PDF
Samuel L Aitken and others
Open Forum Infectious Diseases, Volume 9, Issue Supplement_2, December 2022, ofac492.1473, https://doi.org/10.1093/ofid/ofac492.1473
Published: 15 December 2022
Journal Article

Variation in Clinical Practice and Attitudes on Antibacterial Management of Fever and Neutropenia in Patients With Hematologic Malignancy: A Survey of Cancer Centers Across the United States

PDF
Jason N Barreto and others
Open Forum Infectious Diseases, Volume 9, Issue 3, March 2022, ofac005, https://doi.org/10.1093/ofid/ofac005
Published: 04 February 2022
Journal Article

Contemporary Clinical and Molecular Epidemiology of Vancomycin-Resistant Enterococcal Bacteremia: A Prospective Multicenter Cohort Study (VENOUS I)

PDF
German A Contreras and others
Open Forum Infectious Diseases, Volume 9, Issue 3, March 2022, ofab616, https://doi.org/10.1093/ofid/ofab616
Published: 23 December 2021
Journal Article

1260. In Vitro Activity of Eravacycline Against Clinically Significant Bacteria Isolated from Patients with Cancer

PDF
Bahgat Gerges and others
Open Forum Infectious Diseases, Volume 8, Issue Supplement_1, November 2021, Pages S718–S719, https://doi.org/10.1093/ofid/ofab466.1452
Published: 04 December 2021
Journal Article

60. Creation and Comparison of a Machine Learning Decision Tree and Traditional Risk Score to Predict Ceftriaxone Resistance in Cancer Patients with E. coli Bacteremia

PDF
Courtney Moc and others
Open Forum Infectious Diseases, Volume 8, Issue Supplement_1, November 2021, Page S41, https://doi.org/10.1093/ofid/ofab466.060
Published: 04 December 2021
Journal Article

542. Use of Bamlanivimab in Cancer Patients with Mild-to-Moderate COVID-19

PDF
Patricia Brock and others
Open Forum Infectious Diseases, Volume 8, Issue Supplement_1, November 2021, Pages S372–S373, https://doi.org/10.1093/ofid/ofab466.741
Published: 04 December 2021
Journal Article

580. Refractory and Resistant CMV Infections in Hematopoietic Cell Transplant Recipients in the Letermovir Primary Prophylaxis Era

PDF
Joseph Sassine and others
Open Forum Infectious Diseases, Volume 7, Issue Supplement_1, October 2020, Page S355, https://doi.org/10.1093/ofid/ofaa439.774
Published: 31 December 2020
Journal Article

305. Prevalence of Ceftriaxone Susceptible, Piperacillin-tazobactam Non-susceptible Escherichia coli Bacteremia in Patients with Hematologic Malignancy

PDF
Sarah L Spitznogle and others
Open Forum Infectious Diseases, Volume 7, Issue Supplement_1, October 2020, Page S150, https://doi.org/10.1093/ofid/ofaa439.348
Published: 31 December 2020